Patent · US Active

Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection

US9241983B2 · kind B2 · utility

0Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2012
Grant dateJan 26, 2016
Priority date
Expiry dateApr 30, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2469/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention encompasses methods and compositions for Ureaplasma infection prevention and/or treatment. In specific cases, the invention concerns vaccines for Ureaplasma, including DNA vaccines. In certain embodiments, the invention regards vaccines directed towards the multiple-banded antigen(s) of Ureaplasma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.